Healio: Rehan Ansari, a researcher at the School of Medicine, said that patients with chronic kidney disease are not at an increased risk for AKI or death after chimeric antigen receptor T-cell therapy.
Healio: Rehan Ansari, a researcher at the School of Medicine, said that patients with chronic kidney disease are not at an increased risk for AKI or death after chimeric antigen receptor T-cell therapy.
